From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Psoriasis Is Common in Children

Pediatric psoriasis was associated with increased rates of serious comorbidities.

Psoriasis is a widespread disease affecting all age groups. Many clinicians believe that psoriasis is rare in children, but epidemiologic studies in this population are sparse. Researchers in Germany assessed the prevalence and comorbidities of juvenile psoriasis. Using a national database of 1.3 million nonselected patients covered by national health insurance, the investigators identified psoriasis and comorbidities by ICD-10 codes assigned during patient visits made in 2005.

In all, 33,981 patients received a diagnosis of psoriasis; the overall prevalence was 2.5%, and the prevalence in children younger than 18 years was 0.71%. The pediatric prevalence rates increased linearly with age, from 0.2% at age 1 year to 1.2% at 18 years. Among patients younger than 20, 2549 patients had psoriasis and 331,758 did not. The overall rate of other illnesses was twice as high in patients with psoriasis as in those without. Pediatric psoriasis was associated with increased rates of hyperlipidemia, obesity, hypertension, diabetes mellitus, and Crohn disease.

The authors identify limitations of the study, including limited evaluation by dermatologists and lack of information about psoriasis type or severity. Guttate psoriasis, which is more common in children and has a more transient course, may be overrepresented. However, the prevalence data appear to be consistent with previous studies. The authors conclude that psoriasis is common in children and that, as in adults, it is associated with considerable comorbidity.

Comment: Diagnosis often does require a dermatologist's eye. For example, diaper-area psoriasis is often underdiagnosed, whereas plaque psoriasis is often misdiagnosed as eczema. Treatment of childhood psoriasis is confounded by a lack of clinical trials and by an absence of FDA labeling of medications for young children. We also need a higher awareness of comorbidities in both children and adults with psoriasis.

Mary Wu Chang, MD

Published in Journal Watch Dermatology December 18, 2009

Citation(s):

Augustin M et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2009 Nov 18; [e-pub ahead of print]. (http://dx.doi.org/10.1111/j.1365-2133.2009.09593.x)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.